140 related articles for article (PubMed ID: 12518722)
1. ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndrome.
Heilmann L; von Tempelhoff GF; Pollow K
Clin Appl Thromb Hemost; 2002 Oct; 8(4):319-24. PubMed ID: 12518722
[TBL] [Abstract][Full Text] [Related]
2. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
Ganzevoort W; Rep A; De Vries JI; Bonsel GJ; Wolf H;
Hypertens Pregnancy; 2007; 26(4):433-45. PubMed ID: 18066962
[TBL] [Abstract][Full Text] [Related]
3. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation.
Toulon P; Halbmeyer WM; Hafner G; Schmitt Y; Randgard B; Odpadlik M; Van Den Eynden C; Wagner C
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):447-54. PubMed ID: 10937806
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
[TBL] [Abstract][Full Text] [Related]
5. ProC global: a new automated screening assay for the evaluation of total function of the protein C system.
Dragoni F; Tormene D; Simioni P; Arcieri P; Avvisati G; Girolami A
Clin Appl Thromb Hemost; 2001 Oct; 7(4):351-5. PubMed ID: 11697723
[TBL] [Abstract][Full Text] [Related]
6. HELLP syndrome and factor V Leiden.
Bozzo M; Carpani G; Leo L; Marcozzi S; Sacchi E; Moroni G; Pardi G
Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):55-8. PubMed ID: 11267721
[TBL] [Abstract][Full Text] [Related]
7. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity.
Gardiner C; Cooper PC; Makris M; Mackie IJ; Malia RG; Machin SJ
Blood Coagul Fibrinolysis; 2002 Mar; 13(2):155-63. PubMed ID: 11914658
[TBL] [Abstract][Full Text] [Related]
9. Protein C global assay in the evaluation of women with idiopathic pregnancy loss.
Sarig G; Lanir N; Hoffman R; Brenner B
Thromb Haemost; 2002 Jul; 88(1):32-6. PubMed ID: 12152673
[TBL] [Abstract][Full Text] [Related]
10. "ProC Global": a functional screening test that predicts recurrent venous thromboembolism.
Grand'Maison A; Bates SM; Johnston M; McRae S; Ginsberg JS
Thromb Haemost; 2005 Mar; 93(3):600-4. PubMed ID: 15735816
[TBL] [Abstract][Full Text] [Related]
11. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
12. Associations between phenotypes of preeclampsia and thrombophilia.
Berks D; Duvekot JJ; Basalan H; De Maat MP; Steegers EA; Visser W
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():199-205. PubMed ID: 26444331
[TBL] [Abstract][Full Text] [Related]
13. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
[TBL] [Abstract][Full Text] [Related]
14. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
[TBL] [Abstract][Full Text] [Related]
16. Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets.
von Tempelhoff GF; Heilmann L; Spanuth E; Kunzmann E; Hommel G
Thromb Res; 2000 Nov; 100(4):363-5. PubMed ID: 11187029
[No Abstract] [Full Text] [Related]
17. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy.
Sarig G; Aberbach I; Schliamser L; Blumenfeld Z; Brenner B
Thromb Haemost; 2006 Nov; 96(5):578-83. PubMed ID: 17080213
[TBL] [Abstract][Full Text] [Related]
18. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.
Alfirevic Z; Roberts D; Martlew V
Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):6-14. PubMed ID: 11803092
[TBL] [Abstract][Full Text] [Related]
19. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
[TBL] [Abstract][Full Text] [Related]
20. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
